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Summary
Background As mobile phone access continues to expand globally, opportunities exist to leverage these technologies to 
support demand for immunisation services and improve vaccine coverage. We aimed to assess whether short message 
service (SMS) reminders and monetary incentives can improve immunisation uptake in Kenya.
Methods In this cluster-randomised controlled trial, villages were randomly and evenly allocated to four groups: 
control, SMS only, SMS plus a 75 Kenya Shilling (KES) incentive, and SMS plus 200 KES (85 KES = USD$1). Caregivers 
were eligible if they had a child younger than 5 weeks who had not yet received a first dose of pentavalent vaccine. 
Participants in the intervention groups received SMS reminders before scheduled pentavalent and measles 
immunisation visits. Participants in incentive groups, additionally, received money if their child was timely 
immunised (immunisation within 2 weeks of the due date). Caregivers and interviewers were not masked. The 
proportion of fully immunised children (receiving BCG, three doses of polio vaccine, three doses of pentavalent 
vaccine, and measles vaccine) by 12 months of age constituted the primary outcome and was analysed with log-
binomial regression and General Estimating Equations to account for correlation within clusters. This trial is 
registered with ClinicalTrials.gov, number NCT01878435.
Findings Between Oct 14, 2013, and Oct 17, 2014, we enrolled 2018 caregivers and their infants from 152 villages into 
the following four groups: control (n=489), SMS only (n=476), SMS plus 75 KES (n=562), and SMS plus 200 KES 
(n=491). Overall, 1375 (86%) of 1600 children who were successfully followed up achieved the primary outcome, full 
immunisation by 12 months of age (296 [82%] of 360 control participants, 332 [86%] of 388 SMS only participants, 
383 [86%] of 446 SMS plus 75 KES participants, and 364 [90%] of 406 SMS plus 200 KES participants). Children in the 
SMS plus 200 KES group were significantly more likely to achieve full immunisation at 12 months of age (relative risk 
1·09, 95% CI 1·02–1·16, p=0·014) than children in the control group.
Interpretation In a setting with high baseline immunisation coverage levels, SMS reminders coupled with incentives 
significantly improved immunisation coverage and timeliness. Given that global immunisation coverage levels have 
stagnated around 85%, the use of incentives might be one option to reach the remaining 15%.
Funding Bill & Melinda Gates Foundation.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
Introduction
Annually, immunisation programmes are estimated to 
save more than 2·5 million lives worldwide.1 However, 
approximately 18·7 million and 20·1 million children do 
not receive the third dose of diphtheria, tetanus toxoid, 
and pertussis-containing antigens (DTP3) or measles 
vaccine, respectively. Global coverage levels have stalled 
at about 85%.2 Innovative interventions that address the 
remaining 15% (ie, the last mile) are needed because this 
subpopulation represents a group of individuals at 
disproportionate risk of disease.
The decade 2010–2019 has been designated the Decade 
of Vaccines, with a renewed focus on improving 
immunisation coverage by major international groups 
and the development of the Global Vaccine Action Plan 
(GVAP).3 A key component of GVAP is the recognition 
that both supply-side and demand-side deficiencies need 
to be addressed to achieve universal immunisation.4 
Efforts to make vaccines accessable to children even in 
the most remote places have made great progress. 
Yet, children remain undervaccinated, which might 
be, in part, because of residual demand-side constraints.
As mobile phone access and ownership continue to 
become more common worldwide,5 opportunities exist to 
leverage mobile-health (mHealth) technologies to target 
demand-side barriers, such as forgetting vaccination 
appointments, not knowing the vaccine schedule, or 
incurring transportation costs, to improve immunisation 
uptake. One of the more commonly deployed demand-
side mHealth interventions is short message service 
(SMS), or text message, reminders. SMS reminders 
significantly  improve both health-seeking behaviours and 
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outcomes in sub-Saharan Africa6–11 and immunisation 
uptake in the USA.12,13 However, the evidence that these 
approaches increase immunisation coverage and 
timeliness in Africa and low-income and middle-income 
countries (LMICs) is insufficient and has predominantly 
focused only on timely pentavalent (DTP, Haemophilus 
influenzae type B [Hib] and Hepatitis B) vaccination.14–19
Another type of demand-generating intervention is the 
provision of conditional incentives for completing a 
desired behaviour. In LMICs, small monetary incentives 
have been applied to yield gains in the uptake of HIV 
testing and adult male circumcision.20,21 In LMICs, 
mobile-money systems are frequently used instead of 
traditional banking systems and allow for the transfer of 
money through personal mobile phones.22 Aside from 
our previous pilot study,16 the use of mobile-money 
incentives to improve vaccination coverage has not been 
previously reported.
The Mobile Solutions for Immunization (M-SIMU) 
cluster-randomised controlled trial aimed to assess 
whether SMS reminders, either with or without mobile-
money incentives, could improve the proportion of 
children fully immunised by their first birthday. 
Secondary outcomes included the effect of these 
interventions on vaccine-specific coverage and timeliness.
Methods
Study design and participants
The M-SIMU study was a four-arm, cluster-randomised 
controlled trial done within the Health and Demographic 
Surveillance System (HDSS) overseen by the Kenyan 
Medical Research Institute (KEMRI) and Centers for 
Disease Control and Prevention (CDC) in Siaya County, 
Nyanza Province. Clusters were villages, as defined by 
HDSS, and were randomly assigned and evenly allocated 
to one of four study groups: control, SMS reminders only 
(SMS only), SMS reminders plus a 75 Kenyan Shillings 
incentive (KES; SMS plus 75 KES, where 85 KES = USD$1 
as of August, 2015) and, SMS reminders plus a 200 KES 
incentive (SMS plus 200 KES). A cluster-randomised 
approach was preferred to an individually randomised 
approach to minimise potential discord if neighbouring 
participants were randomised to different study groups. 
The conduct, analysis, and reporting of results were done 
in accordance with the Consolidated Standards of 
Reporting Trials (CONSORT) guidelines adapted for 
cluster-randomised trials.23
The M-SIMU study was done in rural, western Kenya, an 
area with high prevalence of HIV, tuberculosis, and 
malaria.24 Clusters (ie, villages) were included in the trial if 
they were located within Gem or Asembo districts and 
were within the HDSS boundaries. Clusters were excluded 
if they had ongoing special health programmes or 
immunisation activities that could bias the study outcomes.
The M-SIMU trial recruited HDSS village reporters to 
identify eligible caregivers and their infants. Village 
reporters used mobile phones to send birth notification 
text messages to the RapidSMS server. Birth notifications 
were relayed to field-based community interviewers who 
then screened caregivers of newborns  for eligiblity into 
the study. Inclusion criteria for participation included 
being a caregiver of an infant aged 0–34 days and being a 
Research in context
Evidence before this study
We searched Scopus, Embase, PubMed, Web of Science, 
Global Health, and Cochrane Library database for existing 
evidence of SMS reminders or monetary incentives to improve 
immunisation coverage in low-income countries from 
Jan 1, 1990, to Sept 30, 2013. We used the following search 
terms: “text messag*”, “short message service”, “SMS” 
“information communication technology”, “ICT”, “text 
reminder”, “incentive”, “money”, “payment”, “cash”, “conditional 
transfer”, “conditional cash transfer”, “CCT”, “voucher”, 
“subsidy”, “coupon”, “immunization”, “immunisation”, and 
“vaccination”. We found no examples of randomised controlled 
trials that assessed the efficacy of SMS reminders to improve 
immunisation coverage or immunisation timeliness in 
low-income and middle-income countries. For incentives, we 
found one cluster-randomised controlled trial from rural India 
showing that providing caregivers with lentils if their children 
received diphtheria, tetanus toxoid, and pertussis vaccination 
significantly improved immunisation coverage in children when 
measured in children aged 1–3 years old. We found no studies 
that used incentives in the form of cash or mobile-money to 
improve either immunisation coverage or timeliness.
Added value of this study
To our knowledge, this is the first randomised controlled trial 
that has assessed the effect of SMS reminders, with or without 
monetary incentives, to improve the proportion of fully 
immunised children. A recently published randomised 
controlled trial from Zimbabwe that enrolled children 
presenting to the clinic found significant effects of SMS 
reminders on pentavalent 1, pentavalent 2, and pentavalent 3 
timeliness at respective expanded programme immunisation 
due dates of 6 weeks, 10 weeks, and 14 weeks.
Implications of all the available evidence
Our research and existing evidence suggest that incentives were 
moderately useful in improving immunisation coverage and 
more effective at increasing immunisation timeliness. 
Cost-effectiveness analyses in relation to routine immunisation 
systems and outreach campaigns are needed. Additional studies 
that examine SMS reminders and monetary incentives in study 
populations with lower levels of immunisation coverage and 
timeliness are needed.
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current resident of one of the randomised study villages. 
Exclusion criteria included being a caregiver planning to 
migrate from the study area in the next 6 months, if 
the infant received vaccination other than Bacillus 
Calmette–Guérin (BCG) or polio birth dose, or if the 
caregiver was not willing to vaccinate the child at an 
M-SIMU staffed clinic. Caregivers of infants aged 
35 days and older were excluded because of the close 
temporal proximity to the first pentavalent visit 
scheduled at 6 weeks (ie, 42 days).26 M-SIMU health 
facility recorders were stationed at 24 clinics whose 
catchment area overlapped with all study villages.24 
Mobile phone ownership was not an inclusion or 
exclusion criterion. Participants only needed to have 
access to a mobile phone, whereby access was defined by 
the caregiver. For those participants did not own a 
phone, the enrolment was paused until the participant 
confirmed with the owner of the shared phone that text 
messages and incentives, as applicable, could be sent to 
the mobile phone.
The protocol received ethical clearance from the 
Center Scientific Committee, Scientific Steering 
Committee (SSC), and the KEMRI-Nairobi Ethical 
Review Committee (ERC; SSC#2409). Johns Hopkins 
University Bloomberg School of Public Health and CDC 
deferred ethical clearance to KEMRI-ERC. A detailed 
description of the methods and protocol, including 
content of text message reminders and map of randomly 
assigned villages, has been reported.25 This trial is 
registered with ClinicalTrials.gov, number 01878435.
Randomisation and masking
A baseline survey of vaccination coverage, phone 
ownership, and geographical and demographic 
characteristics was done on March 13 and April 29, 2013, 
to provide data for the randomisation.27 A constrained 
randomisation28 was done with GAUSS Mathematical 
and Statistical System by one of the study investigators, 
which randomly generated 1000 allocations that met the 
following criteria for balance across study arms: within a 
relative 10% for the means of full immunisation coverage, 
phone ownership, distance to the nearest clinic, and 
village population of children 12–23 months old; within a 
relative 25% within each district (Gem or Asembo) for 
the means of full immunisation coverage and phone 
ownership. The randomisation was stratified on district 
so that each study group contained exactly 30 villages 
from Gem and eight villages from Asembo.
The 1000 sequences were labelled with three-digit 
numbers, 000 to 999, each one assigning 38 villages 
to each of the four groupings (A–D). At a public 
randomisation ceremony on Sept 12, 2013, village chiefs 
determined the final randomisation outcome by picking 
numbered balls from a cloth sack to select one of these 
1000 sequences, then picking labelled (study group) 
balls to assign the interventions to the chosen 
allocation.24
All caregivers and their infants (hereby referred to as 
infant-caregiver pairs) were allocated to the same study 
group as the randomised village in which they resided. 
If a caregiver moved during the follow-up period, the 
infant–caregiver pair retained their initial study group 
allocation. Due to the nature of the intervention and 
study design, study participants were not masked to 
their study group allocation. Field staff were not 
informed of a village’s allocation, but this could be 
inferred from some enrolment and follow-up survey 
questions. Data cleaning was done by a statistician 
blinded to the allocation.
Procedures
Participants provided written informed consent and were 
enrolled into the study by community interviewers after 
villages were randomly assigned. After obtaining 
consent, community interviewers sent an enrolment 
SMS to the RapidSMS server that contained the 
caregiver’s phone number, the infant’s birthdate, the 
preferred language to receive SMS reminders (English, 
Kiswahili, or Dholuo), and the infant’s name.
All caregivers received a single text message at 
enrolment welcoming them to the study. For 
the three intervention groups, SMS reminders were sent 
three days and the day before scheduled immunisation 
visits at ages 6 weeks, 10 weeks, and 14 weeks for the 
three doses of pentavalent vaccine and age 9 months for 
measles vaccine using the free and open-source 
RapidSMS platform. Health facility recorders (HFR) 
were present at M-SIMU clinics to document 
immunisation. For immunised children, HFRs sent an 
SMS with the date of immunisations received and any 
change in caregiver’s phone number to the RapidSMS 
server. For pentavalent 2 and pentavalent 3 vaccines, 
their respective due dates were recalculated to be 4 weeks 
from the texted pentavalent date (interval-appropriate 
schedule)26 and reminders were sent accordingly. 
Children who either went undocumented by the HFR or 
who did not receive a pentavalent vaccine had reminders 
sent at 6 weeks, 10 weeks, and 14 weeks.
In addition to receiving SMS reminders, caregivers 
were sent either 75 KES (group 3) or 200 KES (group 4) to 
their mobile phone for each timely dose of pentavalent 
and measles vaccine received, defined as vaccination 
within 2 weeks of the Expanded Programme on 
Immunisations (EPI) scheduled date (ie, pentavalent1 at 
6 weeks, pentavalent2 and pentavalent3 4 weeks after the 
previous pentavalent dose, and measles at 9 months).26 
Incentives were sent to participant’s mobile phones 
using a mobile-money programme22 and through their 
preferred mobile network (eg, Safaricom, Airtel).
For children who were in the two incentive groups, the 
RapidSMS system log was downloaded daily and 
mobile-money delivered to caregivers whose children 
were timely vaccinated. Community interviewers did 
household follow-up visits when children reached 
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12 months of age to document the child’s immunisation 
status with the maternal and child health (MCH) booklet. 
If the MCH booklet was not available, a verbal report of 
immunisation history was taken.
Outcomes
The primary outcome was the proportion of fully 
immunised children by 12 months of age, defined as 
receiving BCG, three doses of polio vaccine, three doses 
of pentavalent vaccine, and measles vaccine. Polio birth 
dose was excluded from the primary outcomes definition 
because this vaccine is recommended to be received 
within the first 2 weeks of life. BCG was included because 
it is recommended up to 59 months of age and could be 
received at any of the pentavalent or measles vaccination 
visits.26 Vaccination coverage at 12 months of age and 
timely vaccination for pentavalent, polio, and measles 
vaccines were predetermined as secondary outcomes. 
Vaccination timeliness was defined as receiving 
vaccination within 2 weeks of the EPI due date for 
individual vaccines. A timely fully immunised child was 
defined as being fully immunised within 2 weeks of the 
measles EPI due date. Sensitivity analyses of pentavalent 
timeliness used an interval-appropriate schedule for 
calculating due dates of pentavalent2 and 
pentavalent3 vaccines, where the new pentavalent due 
date was calculated to be 4 weeks after the receipt of the 
previous pentavalent vaccine.
Data for primary and secondary outcomes came from 
written immunisation records found on the child’s MCH 
booklet at 12-month follow-up visits. As available, MCH 
records were compared with prospectively collected 
immunisation records by HFRs. If there were discrepancies 
between MCH and prospectively-collected data, the health 
facility immunisation registries were consulted. If the 
registries did not resolve the discrepancy, MCH data were 
used. The MCH booklet was chosen as the primary source 
document because it was independent of the HFR-collected 
data. Infant–caregiver pairs were considered lost to follow-
up if they outmigrated or the infant died before 12 months 
of age. Verbal reports of immunisation at 12-month 
household follow-up visits, in the absence of written 
documentation, were excluded from the analytic sample.
Statistical analysis
Sample size calculations found that 152 villages were 
needed to detect a 15% absolute difference in the 
proportion of fully immunised children at 12 months of 
Figure 1: Trial profile
SMS=short message service. KES=Kenyan Shilling. *Villages that immediately bordered villages that were excluded because of eligibility requirements.
221 villages assessed for eligibility
152 randomly assigned
69 villages excluded
 56 villages did not meet inclusion criteria
 13 other*
 38 villages assigned to control
 558 participants assessed for
  eligibility
 489 enrolled
 61 ineligible 
 8 refused participation
93 participants lost to 
 follow-up
 77 outmigration
 15 death
 1 withdrew
Primary outcome measured at
12 months
360 participants from 37 villages
Primary outcome measured at
12 months
388 participants from 38 villages
Primary outcome measured at
12 months
446 participants from 38 villages
Primary outcome measured at
12 months
406 participants from 38 villages
67 participants lost to 
 follow-up
 54 outmigration
 13 death
 0 withdrew
86 participants lost to 
 follow-up
 67 outmigration
 17 death
 2 withdrew
65 participants lost to 
 follow-up
 50 outmigration
 15 death
 0 withdrew
 38 villages assigned to SMS only
 550 participants assessed for
  eligibility
 476 enrolled
 63 ineligible
 11 refused participation
 38 villages assigned to SMS plus  
  75 KES
 619 participants assessed for
  eligibility
 562 enrolled
 52 ineligible
 5 refused participation
 38 villages assigned to SMS plus 
  200 KES
 543 participants assessed for
  eligibility
 491 enrolled
 49 ineligible
 3 refused participation
36 participants verbally 
  reported immunisation
21 participants verbally 
  reported immunisation
30 participants verbally 
  reported immunisation
20 participants verbally 
  reported immunisation
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age between the control group and any given 
intervention group. A priori, we selected a 15% difference 
as a meaningful outcome as this represents an effect 
size that would motivate policy makers to adapt the 
interventions. The following assumptions were made 
for sample size calculations: a baseline coverage of fully 
immunised children of 70% at 12 months, village birth 
cohort with harmonic mean of 16 newborns, a 
between-cluster coefficient of variation (k) of 0·25, a 
25% loss to follow-up, a type I error (α) of 0·05, and 
power (1-beta) of 0·80.
Primary analyses were done with modified 
intention-to-treat analyses at the participant level so 
that participants’ outcomes were analysed regardless of 
the degree of exposure to study interventions. The term 
modified refers to the requirement of being able to 
determine the 12-month immunisation outcomes. Risk 
ratios for primary and secondary outcomes were 
calculated for the intervention groups compared with 
the control group using log-binomial regression29 and 
General Estimating Equations (GEE) to account for 
correlation within clusters. As a secondary analysis of 
the primary outcome, time-to-immunisation curves 
were constructed with the Kaplan–Meier method. To 
assess the heterogeneity of treatment effects by various 
risk factors at baseline, the log-binomial models were 
extended and interaction terms were tested. Subgroup 
analyses by phone ownership and time to clinic were 
prespecified. An additional six subgroups were 
analysed by study group to explore potential effect 
modification. Based on the 18 post-hoc subgroup 
interaction analyses, about one statistically significant 
test of interaction (p<0·05) would be expected on the 
basis of chance alone. Socioeconomic status was 
derived from multiple correspondence analysis of 
household possessions to produce quintile scores and 
then dichotomised into bottom 40% and upper 60%. 
Years of maternal education were collected as a 
continuous variable and dichotomised to align with the 
number of years needed to complete primary school in 
Kenya (8 years).
Per-protocol analyses of SMS reminders delivered were 
done for primary and secondary outcomes; per-protocol 
was defined as being sent the appropriate number of 
reminders per vaccine. Sensitivity analyses of vaccination 
coverage and timeliness were done with an interval-
appropriate schedule of the pentavalent series. Analyses 
were done with STATA/SE (version 14.1; Stata Corp, 
College Station, TX, USA). An α of 0·05 was assumed for 
all statistical tests of significance.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
Between Oct 14, 2013, and Oct 17, 2014, we enrolled 
2018 caregivers and their infants (infant-caregiver pairs) 
from 152 villages (figure 1) to meet sample size 
requirements. The number of infant-caregiver pairs 
enrolled in control, SMS only, SMS plus 75 KES, and 
SMS plus 200 KES groups were 489 infant-caregiver 
pairs (38 villages), 476 infant-caregiver pairs (38 villages), 
562 infant-caregiver pairs (38 villages), and 491 infant-
caregiver pairs (38 villages), respectively. After accounting 
for loss to follow-up, which included outmigration and 
death, and excluding caregivers who verbally reported 
their child’s immunisation history, the primary analytic 
sample contained 1600 infant–caregiver pairs who 
completed a 12-month follow-up survey and provided 
MCH booklet information for immunisation history; 
Control 
(n=360)
SMS only 
(n=388)
SMS plus 75 KES 
(n=446)
SMS plus 200 
KES (n=406)
Total (n=1600)
Average cluster size 10 (6) 10 (5) 12 (6) 11 (6) 11 (6)
Mobile phone access
Shares phone 178 (49%) 183 (47%) 236 (53%) 213 (52%) 810 (51%)
Owns phone 182 (51%) 205 (53%) 210 (47%) 193 (48%) 790 (49%)
Mobile network
Safaricom 343 (95%) 378 (97%) 440 (99%) 396 (98%) 1557 (97%)
Other 17 (5%) 10 (3%) 6 (1%) 10 (1%) 43 (3%)
Infant’s sex
Female 186 (52%) 179 (46%) 228 (51%) 207 (51%) 800 (50%)
Male 174 (48%) 209 (54%) 218 (49%) 199 (49%) 800 (50%)
Infant age at 
enrolment (days)
14 (8) 14 (8) 14 (8) 14 (8) 14 (8)
Socioeconomic status
Bottom 40% 132 (37%) 144 (37%) 181 (41%) 172 (42%) 629 (39%)
Upper 60% 228 (63%) 244 (63%) 265 (59%) 234 (58%) 971 (61%)
Time to clinic
≤30 min 202 (56%) 225 (58%) 293 (66%) 255 (63%) 975 (61%)
>30 min 158 (44%) 163 (42%) 153 (34%) 151 (37%) 625 (39%)
Maternal education
≤7 years 83 (23%) 97 (25%) 124 (28%) 107 (26%) 411 (26%)
>7 years 277 (77%) 291 (75%) 322 (72%) 299 (74%) 1189 (74%)
Maternal age*
≤25 years 174 (49%) 203 (53%) 221 (50%) 227 (56%) 825 (52%)
>25 years 184 (51%) 183 (47%) 223 (50%) 179 (44%) 769 (48%)
Number of children younger than 5 years in house
≤1 122 (34%) 133 (34%) 146 (33%) 157 (39%) 558 (35%)
>1 238 (66%) 255 (66%) 300 (67%) 249 (61%) 1042 (65%)
Region
Asembo 75 (21%) 87 (22%) 92 (21%) 81 (20%) 335 (21%)
Gem 285 (79%) 301 (78%) 354 (79%) 325 (80%) 1265 (79%)
Place of last delivery
At home 83 (23%) 110 (28%) 139 (31%) 113 (28%) 445 (28%)
Health Facility 277 (77%) 278 (72%) 307 (69%) 293 (72%) 1155 (72%)
Data are mean (SD) or n (%). SMS=short message service. KES=Kenyan Shilling. *Six missing values.
Table 1: Demographics and baseline characteristics of study participants from Gem and Asembo districts 
(Kenya), 2013–15 
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360 (74%) infant–caregiver pairs from 37 villages (control 
arm), 388 (82%) pairs from 38 villages (SMS only), 
446 (79%) pairs from 38 villages (SMS plus 75 KES), and 
406 (83%) pairs from 38 villages (SMS plus 200 KES). 
Approximately 1600 (94%) of 1707 children who were 
alive and had not outmigrated had an MCH booklet 
present at 12-month follow-up. Sociodemographic 
characteristics of the analytic sample were similar across 
the four groups; notably, 49% of enrolled caregivers 
reported owning a mobile phone (table 1). Of the 
810 (51%) of 1600 participants who shared a mobile 
phone, 456 (56%) of 810 used their husband’s phone to 
receive text message reminders and incentives 
(appendix). Caregivers in the analytic sample were more 
likely to be older and have more children aged younger 
than 5 years old compared with those who were lost to 
follow-up or who did not have an MCH booklet 
(appendix). The coefficient of intercluster variation (k) 
for the primary outcome, a fully immunised child by 
12 months of age, was calculated to be 0·089 in control 
group participants.
Data from the RapidSMS system’s log showed that, 
overall, 4200 (85%) of 4960 vaccine doses (pentavalent 1–3 
and measles) had two SMS reminders sent per protocol, 
and 4797 (97%) of 4960 vaccine doses had at least one 
SMS reminder sent (appendix). Mobile-money incentives 
were sent to caregivers for all timely vaccines given at 
M-SIMU clinics; 54% of incentives were delivered within 
48 h of the immunisation date (data not shown).
The proportions of children achieving the primary 
outcome, full immunisation by 12 months of age, were 
82% (296 of 360) in control, 86% (332 of 388) in SMS only, 
86% (383 of 446) in SMS plus 75 KES, and 90% (364 of 
406) in SMS plus 200 KES groups (table 2). Children who 
were in villages randomly assigned to receive SMS 
reminders plus a 200 KES incentive were more likely to 
achieve full immunisation (risk ratio [RR] 1·09, 95% CI 
1·02–1·16, p=0·014) than control group children. There 
were no significant differences in the primary outcome in 
either the SMS only or SMS plus 75 KES groups compared 
with the control arm. As a secondary outcome, children in 
the SMS plus 200 KES group were significantly more 
likely to receive measles vaccination by 12 months of age 
(1·07, 1·01–1·14, p=0·034) than control group children. 
There were no significant differences in secondary 
outcomes of vaccine-specific coverage estimates in SMS 
only and SMS plus 75 KES groups compared with the 
control group. Per-protocol analyses for delivering SMS 
reminders found similar estimates of vaccination coverage 
Control 
(n=360)
SMS only (n=388)* p 
value†
SMS plus 75 KES (n=446)* p value† SMS plus 200 KES (n=406)* p 
value†
Primary outcome at 12 months
Fully 
immunised 
child‡
296 (82%) 332 (86%); 1·04 (0·97–1·12) 0·29 383 (86%); 1·04 (0·96–1·11) 0·33 364 (90%); 1·09 (1·02–1·16) 0·014
Vaccines in primary outcome
BCG§ 360 (100%) 382 (98%); 0·99 (0·82–1·18) 0·88 444 (100%); 1·00 (0·83–1·19) 0·96 405 (100%); 1·00 (0·83–1·19) 0·97
Pentavalent1§ 359 (100%) 387 (100%); 1·00 (0·87–1·15) 0·99 444 (100%); 1·00 (0·87–1·014) 0·98 406 (100%); 1·00 (0·87–1·15) 0·97
Pentavalent2 356 (99%) 383 (99%); 1·00 (0·98–1·01) 0·77 442 (99%); 1·00 (0·99–1·02) 0·85 404 (100%); 1·01 (0·99–1·02) 0·42
Pentavalent3 353 (98%) 375 (97%); 0·98 (0·96–1·01) 0·20 439 (98%); 1·00 (0·98–1·02) 0·82 401 (99%); 1·01 (0·99–1·02) 0·58
Polio1§ 359 (100%) 386 (99%); 1·00 (0·87–1·14) 0·97 444 (100%); 1·00 (0·87–1·14) 0·98 406 (100%); 1·00 (0·88–1·15) 0·97
Polio2 355 (99%) 383 (99%); 1·00 (0·98–1·02) 0·91 442 (99%); 1·00 (0·99–1·02) 0·76 404 (100%); 1·01 (0·99–1·02) 0·40
Polio3 349 (97%) 372 (96%); 0·98 (0·95–1·01) 0·29 436 (98%); 1·00 (0·98–1·03) 0·85 401 (99%); 1·01 (0·99–1·04) 0·30
Measles 302 (84%) 338 (87%); 1·04 (0·97–1·11) 0·28 388 (87%); 1·03 (0·97–1·10) 0·36 365 (90%); 1·07 (1·01–1·14) 0·034
Data are n (%) and RR (95% CI) for 1600 children with immunisation data recorded on maternal and child health booklet at 12 months. SMS=short message service. 
KES=Kenyan Shilling. *Risk ratios and 95% CIs were calculated using General Estimating Equations with an exchangeable correlation matrix to account for correlation within 
clusters. †Compared with the control group. ‡ k=0·089 in the control group; k=0·069 in the SMS only group; k=0·073 in the SMS plus 75 KES group; k=0·053 in the SMS plus 
200 KES group. §Poisson error distribution used because of model convergence issues.
Table 2: Effects of interventions on primary outcome of full vaccination coverage at 12 months of age in study participants from Gem and Asembo 
districts, Kenya, 2013–15
Figure 2: Effect of interventions on time to immunisation
SMS=short message service. KES=Kenyan Shilling.
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and associations with study groups as intention-to-treat 
analyses (appendix). As a secondary analysis, the median 
ages of achieving full immunisation with survival analysis 
were 288 days (IQR 277–311) in the control group, 
284 (IQR 276–302) in the SMS only group, 
280 (IQR 273–297) in the SMS plus 75 KES group, and 
278 (IQR 273–291) in the SMS plus 200 KES group 
(figure 2). Bimodality in delayed immunisation was not 
observed (appendix)
The secondary outcome of achieving timely full 
immunisation, defined as being fully immunised within 
2 weeks of the measles vaccine EPI due date, was 
significantly higher in all three intervention groups 
compared with the control group (table 3): SMS only 
(RR 1·18, 95% CI 1·01–1·39, p=0·045), SMS plus 75 KES 
(1·37, 1·18–1·59, p<0·0001), and SMS plus 200 KES 
(1·42, 1·23–1·65, p<0·0001). Exploratory analyses found 
that 41% (148 of 360), 48% (187 of 388), 60% (266 of 446), 
and 62% (252 of 406) of control, SMS only, SMS plus 
75 KES, and SMS plus 200 KES children, respectively, 
received all pentavalent series and measles vaccines 
within 2 weeks of their respective EPI due dates of 
6 weeks, 10 weeks, 14 weeks, and 9 months. Coverage 
was significantly higher in the SMS plus 75 KES (1·42, 
1·19–1·71, p<0·0001) and SMS plus 200 KES (1·52, 
1·27–1·81, p<0·0001) groups.
Risk ratios for timely measles vaccination were similar 
to timely fully immunised child estimates (table 3). 
Children in the SMS plus 200 KES group were more 
likely to receive pentavalent 3 vaccination within 2 weeks 
of the EPI due date compared with children in the 
control group (RR 1·12, 95% CI 1·03–1·22, p=0·0092), 
but were no longer significantly associated with timely 
pentavalent3 vaccination when applying an interval-
appropriate schedule to the pentavalent series 
(appendix). We observed no effect of the interventions 
on timely vaccination for either pentavalent1 or 
pentavalent2 vaccination (table 3). Similar findings for 
vaccination timeliness were observed in per-protocol 
analyses, with the exception of pentavalent 2; which had 
significantly higher timeliness in study groups SMS 
plus 75 KES (1·06, 1·00–1·12, p=0·045) and SMS plus 
200 KES (1·09, CI 1·03–1·15, p=0·002; appendix) than 
in the control group.
We found significant effects of SMS plus 200 KES in 
many of the disadvantaged populations, including those 
whose caregivers share a mobile phone, who are female 
children, who have caregivers in the bottom 40% bracket 
of socioeconomic status, who lived more than 30 min 
walking time to a clinic, and who had less than 8 years of 
education (table 4). We found significant stratum-specific 
risk ratios for maternal education across the three study 
groups compared with the control group, although the 
overall interaction was not significant (p=0·08, 3 degrees 
of freedom test). Children of caregivers with up to 7 years 
of education were more likely to be fully immunised than 
those with caregivers who had 8 or more years of 
education in the SMS group (RR 1·26, 95% CI 1·04–1·52, 
p=0·020), SMS plus 75 KES group (1·28, 1·06–1·53, 
p=0·012), and SMS plus 200 KES group (1·29, 1·07–1·55, 
p=0·039) compared with children in the control group. 
We observed similar findings of the intervention’s effect 
on traditionally marginalised populations for timely 
measles and pentavalent3 vaccination (appendix). 
Subgroup analyses for pentavalent1 and pentavalent2 
vaccinations were not done because of high levels of 
timeliness in the control group.
The vast majority of caregivers reported receiving at 
least one SMS reminder or incentive during the study and 
that these interventions were influential in their decision 
to vaccinate their child (table 5). The three most common 
uses of incentives were to pay for housing expenditures 
(342 of [46%] 747), purchase food (247 [33%] of 747), and 
for transportation (67 [9%] of 747). All caregivers, except 
one, said they would retain their enthusiasm for 
vaccination for a future child even if the incentives were 
not given. We observed no indirect benefit of interventions 
on health outcomes or non-vaccine health seeking 
Control 
(n=360)
SMS only (n=388)* p value† SMS plus 75 KES (n=446)* p value† SMS plus 200 KES 
(n=406)*
p value†
Fully immunised 
child‡
181 (50%) 228 (59%); 1·18 (1·00–1·39) 0·045 312 (70%); 1·37 (1·18–1·59) <0·0001 291 (72%); 1·42 (1·23–1·65) <0·0001
Vaccines in fully immunised children§
Pentavalent1 328 (91%) 347 (89%); 0·98 (0·94–1·03) 0·47 412 (92%); 1·01 (0·97–1·06) 0·55 377 (93%); 1·02 (0·98–1·06) 0·40
Pentavalent2 303 (84%) 320 (82%); 0·98 (0·92–1·05) 0·54 387 (87%); 1·03 (0·97–1·09) 0·31 359 (88%); 1·05 (0·99–1·11) 0·093
Pentavalent3 267 (74%) 288 (74%); 1·01 (0·91–1·11) 0·90 354 (79%); 1·07 (0·98–1·17) 0·16 337 (83%); 1·12 (1·03–1·22) 0·0092
Measles 183 (51%) 231 (60%); 1·18 (1·01–1·38) 0·038 316 (71%); 1·37 (1·19–1·59) <0·0001 292 (72%); 1·42 (1·23–1·63) <0·0001
Receiving all 
timely vaccines§
148 (41%) 187 (48%); 1·20 (0·98–1·46) 0·075 266 (60%); 1·42 (1·19–1·71) 0·0001 252 (62%); 1·52 (1·27–1·81) <0·0001
Data are n (%) and risk ratio (95% CI) for 1600 children with immunisation data recorded on maternal and child health booklet at 12 months. SMS=short message service. 
KES=Kenyan Shilling. *Risk ratios and 95% CI were adjusted to account for correlation within clusters. †As compared to control arm. ‡Timeliness defined as receiving 
vaccination within 2 weeks of EPI due date and for fully immunised child, 2 weeks within the measles due date. §Children who received pentavalent 1, pentavalent 2, 
pentavalent 3, and measles vaccines within 2 weeks of their respective EPI due date.
Table 3: Effect of interventions on secondary outcome of vaccination timeliness in study participants from Gem and Asembo districts, Kenya, 2013–15
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behaviours (appendix). In analyses that adjusted for 
demographic differences between the analytic sample and 
participants who were lost to follow-up, children in the 
SMS plus 200 KES group were less likely to outmigrate 
than those in the control group.
Discussion
This study shows that in a rural sub-Saharan African 
setting with high baseline immunisation coverage, SMS 
reminders plus monetary incentives were modestly 
effective at improving the proportion of children fully 
vaccinated by 12 months of age and SMS reminders, with 
or without incentives, yielded significant gains in 
timeliness of measles vaccination. Importantly, the 
incentives seemed to have an equitable effect, 
significantly improving timely vaccination across 
measured sociodemographic characteristics. Lower-
income families must balance the direct and opportunity 
costs of seeking health care with the perceived benefits of 
curative and preventive services, where individuals might 
place greater emphasis on benefits that are immediate, 
such as treatment, compared with those that are delayed, 
like preventive services and immunisations.30 In our 
study and others,31,32 the use of small monetary incentives 
might have served as a nudge for caregivers to seek 
timely immunisation services for their children. This 
study adds to the growing body of scientific literature 
that shows strong effects of demand-side interventions 
for immunisation coverage in LMICs.33
Notably, we were able to observe significant effects of 
the mobile phone-delivered interventions in a study 
population comprised equally of those who reported 
owning or sharing a mobile phone. By enrolling 
caregivers who shared a mobile phone, it was implicit 
that caregivers would need to discuss with the phone 
owner that SMS messages and incentives would need to 
be relayed from phone owner to intended recipient. More 
than 90% of enrolled caregivers reported receiving 
at least one SMS or incentive, as applicable. When 
combined with our subgroup analyses, this result 
suggests that the interventions were successfully relayed. 
The exact nature of this transfer, and whether there were 
any informal transactional costs in those who received 
incentives, is not well understood, but future focus group 
discussions might provide further insight.
As the use of economic incentives becomes more 
widespread, there have been considerable discussions 
regarding the ethics of this approach.34 The incentive 
amounts in this study were not coercive; they were less 
than one day’s working wage21 and were targeted to a 
Control (n=360) SMS (n=388) Stratum-specific RR p value* SMS plus 75 
KES (n=446)
Stratum-specific 
RR
p value* SMS plus 200 KES 
(n=406)
Stratum-specific 
RR
p value*
Phone access
Owns 156/182 (86%) 181/205 (88%) 1·03 (0·95–1·12) 0·79 183/210 (87%) 1·01 (0·92–1·10) 0·35 179/193 (93%) 1·08 (1·00–1·16) 0·72
Shares 140/178 (79%) 151/183 (83%) 1·05 (0·94–1·17) ·· 200/236 (85%) 1·07(0·96–1·18) ·· 185/213 (87%) 1·10 (1·00–1·22) ··
Infant sex
Male 146/174 (84%) 177/209 (85%) 1·01 (0·93–1·10) 0·34 188/218 (86%) 1·03 (0·95–1·12) 0·61 181/199 (91%) 1·08 (1·00–1·17) 0·85
Female 150/186 (81%) 155/179 (87%) 1·07 (0·98–1·18) ·· 195/228 (86%) 1·06 (0·97–1·16) ·· 183/207 (88%) 1·10 (1·01–1·19) ··
Socioeconomic status
Bottom 40% 101/132 (77%) 112/144 (78%) 1·02 (0·89–1·16) 0·62 153/181 (85%) 1·10 (0·99–1·24) 0·21 152/172 (88%) 1·15 (1·04–1·29) 0·19
Top 60% 195/228 (86%) 220/244 (90%) 1·05 (0·99–1·13) ·· 230/265 (87%) 1·01 (0·94–1·09) ·· 212/234 (91%) 1·06 (0·99–1·13) ··
Time to clinic
≤30 min 167/202 (83%) 193/225 (86%) 1·04 (0·96–1·13) 0·92 255/293 (87%) 1·05 (0·97–1·14) 0·68 226/255 (89%) 1·07 (0·99–1·16) 0·47
>30 min 129/158 (82%) 139/163 (85%) 1·04 (0·95–1·15) ·· 128/153 (84%) 1·02 (0·93–1·13) ·· 138/151 (91%) 1·12 (1·02–1·22) ··
Maternal education
≤7 years 53/83 (64%) 78/97 (80%) 1·26 (1·04–1·52) 0·020 101/124 (81%) 1·28 (1·06–1·53) 0·012 88/107 (82%) 1·29 (1·07–1·55) 0·039
>7 years 243/277 (88%) 254/291 (87%) 0·99 (0·94–1·06) ·· 282/322 (88%) 1·00 (0·94–1·06) ·· 276/299 (92%) 1·05 (1·00–1·11) ··
Maternal age†
≤25 years 147/174 (84%) 179/203 (88%) 1·04 (0·96–1·13) 0·87 201/221 (91%) 1·08 (1·00–1·16) 0·34 206/227 (91%) 1·07 (1·00–1·16) 0·72
>25 years 148/184 (80%) 152/183 (83%) 1·03 (0·94–1·14) ·· 182/223 (82%) 1·01 (0·92–1·12) ·· 158/179 (88%) 1·10 (1·00–1·20) ··
Children younger than 5 years in the house
≤1 105/122 (86%) 118/133 (89%) 1·03 (0·94–1·13) 0·82 132/146 (90%) 1·05 (0·96–1·15) 0·90 146/157 (93%) 1·08 (0·99–1·17) 0·87
1 191/238 (80%) 214/255 (84%) 1·05 (0·96–1·14) ·· 251/300 (84%) 1·04 (0·96–1·13) ·· 218/249 (88%) 1·09 (1·01–1·18) ··
Region
Gem 228/285 (80%) 254/301 (84%) 1·05 (0·97–1·15) 0·45 303/354 (86%) 1·06 (0·98–1·15) 0·21 289/325 (89%) 1·11 (1·02–1·20) 0·28
Asembo 68/75 (91%) 78/87 (90%) 1·00 (0·89–1·12) ·· 80/92 (87%) 0·96 (0·85–1·09) ·· 75/81 (93%) 1·03 (0·93–1·14) ··
Data are n/N (%) and RR (95% CI) for 1600 children with immunisation data recorded on maternal and child health booklet at 12 months. SMS=short message service. KES=Kenyan Shilling. RR=risk ratios. 
*p values obtained from an interaction term between intervention groups and risk factor. †Six missing values.
Table 4: Subgroup analyses of full immunisation coverage at 12 months of age in study participants from Gem and Asembo districts, Kenya, 2013–15
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routine care-seeking practice and not paired to risky or 
dangerous behaviour. Incentives were effective in many 
of the marginalised subpopulations and therefore did not 
seem to exacerbate any existing inequities. Future studies 
need to address whether their application created a 
dependency. If incentives can improve immunisation 
coverage and timeliness, subsequently higher coverage 
levels would induce herd immunity for some of the 
vaccine preventable diseases and confer health and 
economic benefits to people who do not receive incentives.
A common critique of incentives focuses on 
sustainability and scalability. To address these concerns, 
first, replication studies, including urban settings and 
areas with low immunisation coverage, are needed 
before recommending incentives as a way for improving 
immunisation rates. Second, incentives must be 
cost-effective. Aside from the economic savings 
associated with treatment cost and productivity loss,35 the 
use of incentives, at least in this study area, might be 
cost-effective or even cost-neutral if they significantly 
strengthen the routine immunisation services, thereby 
reducing the need for supplemental and out-reach 
immunisation activities. Costing analyses are underway 
at present. Lastly, the application of incentives could be 
selectively targeted to districts with poor immunisation 
rates or for particular vaccines that exhibit low 
population coverage levels, such as measles or human 
papillomavirus. A targeted approach of delivering 
incentives to subpopulations within Kenya is not novel.36
This study has several strengths. First, selection bias 
was minimised by enrolling infants at home shortly after 
birth, rather than enrolling from a health facility. 
Enrolment of infants before their first vaccination ensures 
that the study sample was representative of its population 
by including infants who might not go for any vaccines. 
Second, this trial was designed and implemented to 
closely mimic an effectiveness study and with scalability 
in mind by enrolling caregivers independent of mobile 
phone ownership, a study design unlike some m-health 
intervention trials that provide a mobile phone7 or require 
one for enrolment.8,14,37 We do not believe the high coverage 
estimates observed in the control group were due to study 
participation (ie, Hawthorne effect) because the coverage 
was similar to that in a baseline survey done before the 
trial.27 Moreover, we sought to minimally interfere with 
participants’ care-seeking behaviours because household 
visits were only done at enrolment and 12-month follow-
up. Lastly, our per-protocol analyses of SMS reminder 
delivery and sensitivity analyses of pentavalent interval-
appropriate schedules largely mirrored our intention-to-
treat and MCH booklet data source analyses.
The absence of a significant association between 
participants in the SMS only  group and the primary 
outcome of immunisation coverage at 12 months 
contradicts positive findings from the majority of SMS 
reminder randomised controlled trials done in sub-Saharan 
Africa and Kenya.6–11 However, we found SMS reminders 
significantly improved timely measles immunisation, a 
secondary outcome. The success of SMS reminders to 
elicit a behaviour is multifactorial; the content of the 
message, the type of behaviour being reminded, indirect 
and direct costs incurred, literacy level, and other 
contextual factors all being potential explanatory factors. 
SMS reminders were probably not effective at improving 
full immunisation and vaccine-specific coverages in this 
study because of high baseline coverage levels and because 
SMS reminders might not have addressed the demand-
side deficiencies in this study area. Similarly, investigators 
have reported that two-way messages are more effective 
than one-way messages, as used in M-SIMU, for 
medication adherence.38 Future studies using SMS 
reminders in areas of low vaccination coverage are needed.
This study has several limitations. First, our analytic 
sample consisted of 79% of enrolled caregiver–infant 
pairs. We anticipated a loss to follow-up given the study 
SMS only SMS plus 75 KES SMS plus 200 KES
Received any SMS reminder during study
Yes 354/382 (93%) 419/446 (94%) 394/405 (97%)
Caregiver’s opinion on number of SMS reminders per vaccine*
Just right 274/281 (98%) 310/316 (98%) 302/307 (98%)
Too few 3/281 (1%) 6/316 (2%) 3/307 (1%)
Too many 4/281 (1%) 0/316 (<1%) 2/307 (1%)
SMS influenced decision to vaccinate child
Yes 296/354 (84%) 355/419 (85%) 332/394 (84%)
Received any incentive during study
Yes ·· 387/446 (87%) 360/406 (89%)
Incentive influenced decision to vaccinate child
Yes ·· 304/387 (79%) 260/360 (72%)
Intervention most influential for decision to vaccinate child
SMS ·· 253/387 (65%) 236/360 (66%)
Incentive ·· 30/387 (8%) 31/360 (9%)
Neither ·· 12/387 (3%) 12/360 (3%)
SMS and incentive equally ·· 92/387 (24%) 81/360 (23%)
Likelihood of vaccinating future child without an incentive
Less likely ·· 0/387 1/360 (<1%)
The same ·· 114/387 (29%) 151/360 (42%)
More likely ·· 273/387 (71%) 208/360 (58%)
Incentive used for†
Housing expenses ·· 164/387 (42%) 178/360 (49%)
Food ·· 116/387 (30%) 131/360 (36%)
Transportation ·· 52/387 (13%) 15/360 (4%)
Clothes for child ·· 8/377 (2%) 31/360 (9%)
Mobile phone airtime ·· 34/387 (9%) 1/360 (<1%)
Not used by mother ·· 4/387 (1%) 1/360 (<1%)
Didn’t cash out incentive ·· 4/387 (1%) 1/360 (<1%)
Other ·· 13/387 (3%) 14/360 (4%)
Data are n/N (%) and come from a household survey done at child’s age of 12 months. SMS=short message service. 
KES=Kenyan Shilling. *Data missing for 262 caregivers who reported sharing a mobile phone and not being able to 
provide an opinion. †Percentages do not sum to 100% because caregivers could select more than one option.
Table 5: Opinions of SMS reminders and mobile-money incentives from study participants from Gem and 
Asembo districts, Kenya, 2013–15
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area’s trends in outmigration25 and adjusted sample 
size accordingly. There were some differences in 
sociodemographic characteristics between the analytic 
sample and those who were excluded from the analysis. 
Excluded caregivers were more likely to be less than 
25 years old, have one child younger than 5 years old in 
the household, and reside in Gem. In this area, there is a 
cultural practice of caregivers migrating to their home 
village to give birth, which might be more common in 
younger mothers who are having their first child. Second, 
although we report high levels of successfully delivering 
SMS reminders and incentives, we do not have complete 
information on whether SMS reminders were received 
and read or if reminders and incentives were relayed to 
enrolled caregivers in those who shared a mobile phone. 
Lastly, although BCG vaccine was not paired with the 
intervention, we included it in our primary outcome for 
concordance with global definitions of fully immunised 
child. The effect of BCG’s inclusion on our estimates of 
full immunisation was minimal: of the nine children 
who did not receive BCG, five children would have been 
classified as not achieving full immunisation for missing 
other vaccinations.
This rural study area has high baseline immunisation 
levels, moderate levels of mobile phone ownership,27 and 
a widespread mobile-money network.22 Replicating this 
trial in settings where mobile phone ownership is lower 
and mobile-money systems are absent or less frequently 
used might not be possible. Nevertheless, components of 
the intervention can be disaggregated into individual 
modules (SMS reminders, incentives, and mobile-
money) and can be applied based on a country’s available 
technology. For example, instead of transferring cash via 
mobile-money, incentives can be given by providing 
mobile phone airtime or even cash vouchers.32 Mobile-
money was used in this trial because of its widespread 
acceptance, its logistical ease of delivery, and the 
avoidance of having cash at a health facility where it 
might present security risks and either be lost or stolen.
In conclusion, the provision of SMS reminders coupled 
with small monetary incentives led to significant, though 
modest improvements in fully immunised child coverage 
and larger gains in immunisation timeliness. We found 
that the interventions were equally effective across all 
subgroups. In other resource-constrained settings where 
immunisation coverage is low, it is likely that SMS 
reminders, with or without incentives, could raise 
immunisation timeliness, but additional research 
is needed.
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